Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth drugs and epidermal growth factor do not change the calcium binding site gradient in hair follicles.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

The mTurq2-Col4a1 mouse model shows that cells can divide while attached to stable basement membranes during development.

Hair loss in androgenic alopecia patients is linked to changes in certain genes that control cell growth and death.

Engineered vesicles with EGF mRNA improve skin wound healing and reduce scarring.

Serenoa repens extract may help hair growth in both men and women.

MLPH helps hair grow by activating IGF-1 signaling in hair cells.

Removing Lrig1-positive cells in mice leads to temporary loss of sebaceous glands.

Engineered exosomes with EGF and FGF improve hair growth in mice with hair loss.

Engineered exosomes with EGF and FGF improved hair growth in mice with hair loss.

Sesamin may help treat hair loss by affecting specific cell pathways.

A genetic variant in "Blonde d'Aquitaine" calves causes death at birth due to a missing protein.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Vitamin B12 is crucial for hair and nerve health, and its malabsorption can cause hair loss and nerve damage.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Hair follicle stem cells can be turned into neuron-like cells, offering a new way for brain repair.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

PRP preparation partially activates platelets, causing varied growth factor release.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

N6-methyladenosine affects hair follicle development differently in Rex and Hycole rabbits.

The method effectively mimics shaving damage on skin for testing skincare products.

Inhibiting EGFR weakens skin's defense against bacteria.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.